Skip to main content
AIRS logo

AIRS

Airsculpt Technologies, Inc.
$4.33 +0.00 (+0.00%) At close · Jul 10
Market Cap
$305.46M
Shares
70,545,681

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$151.82M -15.8%
FY2025 Revenue FY2019–FY2025
Net Income
-$11.67M -45.5%
FY2025 Net Income FY2019–FY2025
Operating Margin
-7.61% -6.7pp
FY2025 Operating Margin FY2019–FY2025
Diluted EPS
-$0.19 -35.7%
FY2025 Diluted EPS FY2021–FY2025
Operating Cash Flow
$3.1M -72.7%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$151M – $157M $151.84M $151.82M $180.35M $195.92M $168.79M $133.32M $62.77M $41.24M
$82.99M $82.18M $98.88M $102.38M $101.42M $65.73M $23.62M $20.13M
$4.8M $4.8M $4.8M $4.8M $4.8M $4.8M $4.8M $4.8M
$12.56M $12.78M $11.89M $10.25M $8.06M $6.6M $5.64M $4.96M
$163.61M $163.38M $181.93M $186.2M $173.34M $117.55M $52.73M $40.57M
-$11.77M -$11.56M -$1.58M $9.72M -$4.55M $15.77M $10.03M $663K
-7.61% -0.88% 4.96% -2.69% 11.83% 15.98% 1.61%
$787K $1.22M $10.31M $19.98M $3.52M $22.37M $15.67M $5.62M
$5.65M $6.08M $6.25M $6.49M $6.75M $4.89M $2.46M $2.88M
-$17.29M -$17.64M -$7.83M $3.24M -$11.3M $10.88M $7.58M -$2.21M
-$6.07M -$5.97M $188K $7.48M $3.38M $329K $0 $0
-$11.22M -$11.67M -$8.02M -$4.24M -$14.68M $10.55M $7.58M -$2.21M
-7.68% -4.45% -2.16% -8.7% 7.91% 12.07% -5.36%
-$11.22M -$11.67M -$8.02M -$4.24M -$14.68M $10.55M
-$10.87M -$11.08M -$8.29M -$4.58M -$14.76M $10.55M $7.58M
USD/shares -$0.19 -$0.14 -$0.08 -$0.26 -$0.01
USD/shares -$0.19 -$0.14 -$0.08 -$0.26 -$0.01
shares 60.45M 57.69M 56.78M 55.68M 55.64M
shares 60.45M 57.69M 56.78M 55.68M 55.64M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2025: $23.8M in dividends.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
2.20×
Medical Care Facilities median 1.28×
EV/EBIT
Medical Care Facilities median 17.93×
P/E (TTM)
Medical Care Facilities median 16.85×

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Reportable Segment $151,818,000 $180,350,000 $195,917,000 $168,794,000

By Geography (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Non Us $4,600,000 $6,100,000 $5,200,000 $300,000 $0

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Reportable Segment -$11,560,000 -$1,583,000 $9,722,000 -$4,545,000

Operating Margin by Segment (%)

Component 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Reportable Segment -7.6% -0.9% 5% -2.7%
Key facts CIK 1870940 CUSIP 009496100 13F (30d) 3 filings 2 filers Visit website Investor relations